About this document
Metabical Demand Strategy Analysis by Anirban Chakraborty is a document available to read on EtoBox.
The document discusses three demand scenarios for the weight loss drug Metabical over its first five years. Scenario 2 is chosen, which targets 34% of the US population (overweight individuals), captures 12% of that group, and prices the drug affordably. This scenario projects $422 million in profit and a 5.7% ROI, meeting management
- Author
- Anirban Chakraborty
- Language
- EN